A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients

NCT04116411 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Valganciclovir Tablets
DRUG: Temozolomide 120 mg
RADIATION: Radiotherapy 60 Gy
DRUG: Placebo oral tablet

Sponsor

Cecilia Soderberg-Naucler

Collaborators

[object Object]
[object Object]